Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 10,031	$ 14,025
Accounts receivable, net of allowance for credit losses	4,951	1,906
Contract assets	1,554	1,604
Inventories	4,658	4,454
Other current assets	592	852
Total current assets	21,786	22,841
Property, plant and equipment, net	12,041	12,166
Other assets	18	18
Total assets	33,845	35,025
Current liabilities
Accounts payable	1,601	1,203
Accrued expenses	1,736	1,765
Current maturities of long-term debt	84	81
Contract liabilities	5,098	4,908
Deposit from purchaser of MesoScribe assets-Note 11	597	597
Total current liabilities	9,116	8,554
Long-term debt, net of current portion	225	268
Total liabilities	9,341	8,822
Stockholders’ equity:
Common stock - $0.01 par value – 20,000,000 shares authorized; issued and outstanding 6,825,338 at June 30, 2024 and 6,824,511 at December 31, 2023	68	68
Additional paid-in capital	29,229	28,695
Accumulated deficit	(4,793)	(2,560)
Total stockholders’ equity	24,504	26,203
Total liabilities and stockholders’ equity	$ 33,845	$ 35,025

Deposits from purchaser of MesoScribe assets.

No definition available.

Name:	CVV_DepositsFromPurchaserOfMesoscribeAssets
Namespace Prefix:	CVV_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).